Adverse events and tolerability of combined durvalumab and tremelimumab versus durvalumab alone in solid cancers: a systematic review and meta-analysis

by Fahmy, Omar, Ahmed, Osama A. A., Khairul-Asri, Mohd Ghani, Alhakamy, Nabil A., Alharbi, Waleed S., Fahmy, Usama A., El-Moselhy, Mohamed A., Fresta, Claudia G., Caruso, Giuseppe, Caraci, Filippo
Published 2022

Updates on molecular and biochemical development and progression of prostate cancer

by Fahmy, Omar, A. Alhakamy, Nabil, Y. Rizg, Waleed, Bagalagel, Alaa, J. Alamoudi, Abdulmohsin, M. Aldawsari, Hibah, M. Khateb, Aiah, M. Eldakhakhny, Basmah, A. Fahmy, Usama, H. Abdulaal, Wesam, G. Fresta, Claudia, Caruso, Giuseppe
Published 2021